Cardiology
From the Journals
Final SPRINT data confirm lower BP is better
The new results are “more robust,” says expert.
Conference Coverage
Sex differences in COPD symptoms predict cardiac comorbidity
“Our findings give hints how diagnostic information might be used differently in men and women.”
Conference Coverage
AHA/ACC guidance on ethics, professionalism in cardiovascular care
A consensus report provides advice and tools to address conflicts of interest; racial, ethnic, and gender inequities; and to improve diversity,...
Conference Coverage
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
Conference Coverage
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
Conference Coverage
Novel rehab program fights frailty, boosts capacity in advanced HF
The program, started in the hospital, worked on capabilities such as mobility, balance, and strength that would be necessary if exercises meant to...
Conference Coverage
New STRENGTH analysis reignites debate on omega-3 CV benefits
The new analysis showing no benefits linked to higher achieved levels of EPA casts doubt over the use of high-dose omega-3 fatty acid products for...
Conference Coverage
Ultrasound renal denervation drops BP in patients on triple therapy
Conference Coverage
ADAPTABLE: Low-dose aspirin as good as high-dose in CHD?
A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found...
Conference Coverage
PARADISE-MI: Sacubitril/valsartan can’t beat ramipril in patients with acute MI
News from the FDA/CDC
Cell phone, smart watch magnets can affect medical devices, FDA says